Steward Partners Investment Advisory’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Steward Partners Investment Advisory's CLBT Position: Q2 2026 in Review
Steward Partners Investment Advisory increased its Cellebrite (CLBT) stake by 8.1% in Q2 2026, buying an estimated $20.4K and bringing the position to 20,582 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #2000.
Steward Partners Investment Advisory first reported a position in CLBT in Q2 2022 and has held it in 17 quarters since. The position peaked at $501K in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Steward Partners Investment Advisory held 20,582 shares of Cellebrite worth $300K as of Q2 2026.
- Steward Partners Investment Advisory bought 1,547 Cellebrite shares in Q2 2026, an estimated $20.4K.
- Cellebrite made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2000 holding.
- Steward Partners Investment Advisory first reported a position in Cellebrite in Q2 2022 and has held it in 17 quarters since.
- Steward Partners Investment Advisory's Cellebrite position peaked at $501K in Q3 2025.
- 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.